NO933575L - Fremgangsmaate for kondisjonering av vannopploeselige stoffer - Google Patents

Fremgangsmaate for kondisjonering av vannopploeselige stoffer

Info

Publication number
NO933575L
NO933575L NO93933575A NO933575A NO933575L NO 933575 L NO933575 L NO 933575L NO 93933575 A NO93933575 A NO 93933575A NO 933575 A NO933575 A NO 933575A NO 933575 L NO933575 L NO 933575L
Authority
NO
Norway
Prior art keywords
conditioning
procedure
water soluble
soluble substances
vacuum
Prior art date
Application number
NO93933575A
Other languages
English (en)
Other versions
NO311867B1 (no
NO933575D0 (no
Inventor
Jan Trofast
Eva Trofast
Katarina Bystroem
Edib Jakupovic
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20382434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO933575(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO933575D0 publication Critical patent/NO933575D0/no
Publication of NO933575L publication Critical patent/NO933575L/no
Publication of NO311867B1 publication Critical patent/NO311867B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Paper (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Cosmetics (AREA)
  • Treating Waste Gases (AREA)
  • Hydrogenated Pyridines (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
NO19933575A 1991-04-11 1993-10-06 Fremgangsmåte for kondisjonering av vannopplöselige stoffer NO311867B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9101090A SE9101090D0 (sv) 1991-04-11 1991-04-11 Process for conditioning of water-soluble substances
PCT/SE1992/000186 WO1992018110A1 (en) 1991-04-11 1992-03-24 Process for conditioning of water-soluble substances

Publications (3)

Publication Number Publication Date
NO933575D0 NO933575D0 (no) 1993-10-06
NO933575L true NO933575L (no) 1993-10-06
NO311867B1 NO311867B1 (no) 2002-02-11

Family

ID=20382434

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19933575A NO311867B1 (no) 1991-04-11 1993-10-06 Fremgangsmåte for kondisjonering av vannopplöselige stoffer

Country Status (28)

Country Link
US (1) US5562923A (no)
EP (3) EP0508969A1 (no)
JP (2) JP3400999B2 (no)
KR (1) KR100216384B1 (no)
AT (2) ATE208613T1 (no)
AU (1) AU662519B2 (no)
BG (1) BG61474B1 (no)
CA (1) CA2106975C (no)
CZ (1) CZ286936B6 (no)
DE (2) DE69210601T2 (no)
DK (2) DK0680752T3 (no)
EE (1) EE02970B1 (no)
ES (2) ES2168322T3 (no)
FI (1) FI105388B (no)
GR (1) GR3020602T3 (no)
HK (1) HK52497A (no)
HU (1) HU211116B (no)
IE (1) IE921144A1 (no)
IS (1) IS3834A (no)
NO (1) NO311867B1 (no)
PL (1) PL168232B1 (no)
PT (1) PT680752E (no)
RO (1) RO115779B1 (no)
RU (1) RU2112507C1 (no)
SE (1) SE9101090D0 (no)
SG (1) SG43180A1 (no)
SK (1) SK280310B6 (no)
WO (1) WO1992018110A1 (no)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5983956A (en) 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
EP0812195B1 (en) 1995-02-28 2002-10-30 Aventis Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol compounds
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
GB9526392D0 (en) * 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
US6495167B2 (en) 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
DE69828155T2 (de) * 1997-03-20 2005-12-22 Schering Corp. Herstellung von pulveragglomeraten
US6503537B2 (en) 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
NZ501248A (en) * 1997-08-26 2001-06-29 Aventis Pharma Inc Pharmaceutical composition for combination of piperidinoalkanol-decongestant
DE69813853T3 (de) * 1997-09-29 2011-05-12 Novartis Ag Perforierte mikroteilchen und deren verwendung
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
FI105074B (fi) 1997-12-31 2000-06-15 Leiras Oy Farmaseuttisen formulaation valmistusmenetelmä
US6287693B1 (en) * 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
SE9804000D0 (sv) 1998-11-23 1998-11-23 Astra Ab New composition of matter
GB9826284D0 (en) * 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
GB9826286D0 (en) 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7309707B2 (en) 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US20040028746A1 (en) * 2002-08-06 2004-02-12 Sonke Svenson Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
GB0228826D0 (en) * 2002-12-11 2003-01-15 Okpala Joseph Hair technology in creating particles with improved delivery capabilities
DE04758472T1 (de) * 2003-03-26 2005-06-23 Teva Pharmaceutical Industries Ltd. Verfahren zur herstellung eines pharmazeutischen wirkstoffs mit hochspezifischer oberfläche
ES2340422T3 (es) * 2003-06-13 2010-06-02 Skendi Finance, Ltd. Microparticulas constituidas por estradiol y colesterol.
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
AU2004281270B2 (en) * 2003-10-17 2010-05-06 E.I. Dupont De Nemours And Company Adhesion of foil to thermoplastic polymers
BRPI0506610A (pt) 2004-02-03 2007-05-02 Chemagis Ltd montelucaste sódico amorfo, processo de preparação de montelucaste sódico amorfo, composição farmacêutica, método de tratamento utilizando a administração de montelucaste sódico amorfo, co-precipitado amorfo de montelucaste sódico e processo de preparação de co-precipitado amorfo de montelucaste sódico
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
DE102004048390A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pulverinhalativa auf Basis modifizierter Laktosemischungen als Hilfsstoff
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
EP2234595B1 (en) * 2007-12-13 2012-11-28 Novartis AG Process for reducing the tendency of a glycopyyronium salt to aggegate during storage.
RU2376079C1 (ru) * 2008-06-11 2009-12-20 Государственное образовательное учреждение высшего профессионального образования "Московский государственный университет инженерной экологии" Способ получения порошков микронизированных частиц
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
WO2011110852A1 (en) 2010-03-10 2011-09-15 Astrazeneca Ab Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide
MX2013014566A (es) 2011-06-29 2014-09-25 Bayer Ip Gmbh Formas cristalinas de derivados de indozolilamida para el tratamiento de transtornos mediados por el receptor glucocorticoide.
US20140275517A1 (en) * 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
WO2021219230A1 (en) 2020-04-30 2021-11-04 Paolo Fiorina Antiviral treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978192A (en) * 1971-09-23 1976-08-31 Sussman Martin V Method of drawing fibers using a microterraced drawing surface
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
US4476130A (en) * 1982-09-09 1984-10-09 Riker Laboratories, Inc. 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity
JPH08186B2 (ja) * 1985-06-21 1996-01-10 ゲルゲリイ、ゲルハルト プロセス材料から反応生成物を製造する方法及びその装置
IT1204826B (it) * 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
PH30058A (en) * 1989-11-24 1996-11-08 Biochemie Gmbh Pancreation preparations
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles

Also Published As

Publication number Publication date
SK108893A3 (en) 1994-03-09
CZ211693A3 (en) 1994-04-13
DE69232207D1 (de) 2001-12-20
SG43180A1 (en) 1997-10-17
NO311867B1 (no) 2002-02-11
DK0580648T3 (da) 1996-09-16
EP0680752A3 (no) 1995-11-22
FI934429A0 (fi) 1993-10-08
EP0580648B1 (en) 1996-05-08
FI934429L (fi) 1993-10-08
ES2168322T3 (es) 2002-06-16
EP0508969A1 (en) 1992-10-14
PT680752E (pt) 2002-05-31
SE9101090D0 (sv) 1991-04-11
PL168232B1 (pl) 1996-01-31
HU9302870D0 (en) 1993-12-28
EP0680752B1 (en) 2001-11-14
JP3400999B2 (ja) 2003-04-28
DE69232207T2 (de) 2002-08-01
HUT65095A (en) 1994-04-28
RU2112507C1 (ru) 1998-06-10
IS3834A (is) 1992-10-12
WO1992018110A1 (en) 1992-10-29
ATE137671T1 (de) 1996-05-15
BG98147A (bg) 1994-12-02
RO115779B1 (ro) 2000-06-30
ES2086733T3 (es) 1996-07-01
EP0580648A1 (en) 1994-02-02
NO933575D0 (no) 1993-10-06
FI105388B (fi) 2000-08-15
DK0680752T3 (da) 2002-02-25
HK52497A (en) 1997-05-02
HU211116B (en) 1995-10-30
IE921144A1 (en) 1992-10-21
EP0680752A2 (en) 1995-11-08
DE69210601T2 (de) 1996-10-02
CA2106975C (en) 2002-03-19
BG61474B1 (en) 1997-09-30
JP2003155228A (ja) 2003-05-27
AU1534792A (en) 1992-11-17
EE02970B1 (et) 1997-04-15
SK280310B6 (sk) 1999-11-08
DE69210601D1 (de) 1996-06-13
CA2106975A1 (en) 1992-10-12
US5562923A (en) 1996-10-08
KR100216384B1 (ko) 1999-08-16
JPH06506454A (ja) 1994-07-21
CZ286936B6 (cs) 2000-08-16
GR3020602T3 (en) 1996-10-31
ATE208613T1 (de) 2001-11-15
AU662519B2 (en) 1995-09-07

Similar Documents

Publication Publication Date Title
NO933575D0 (no) Fremgangsmaate for kondisjonering av vannopploeselige stoffer
RU93058260A (ru) Способ получения водорастворимых микронизированных веществ
ATE117201T1 (de) Antimykotische zusammensetzung in trocken aerosol form.
MY108860A (en) Bloodbag and method of making same
AU2283899A (en) Method for drying a hollow body and implementing device
DE3164422D1 (en) Immunosuppressive compound, process for isolating it and its therapeutical use
AU4047589A (en) Drying polycarbonate membranes
IT7885588A0 (it) Mezzo propellente adinfiammabilita' ridotta per aerosol, procedimento per la suaproduzione e dispositivo per la realizzazione del procedimento.
JPS52150793A (en) Desiccating agent
JPS544061A (en) Test piece chamber for electronic microscope or the like
JPS51142488A (en) Novel photocromic material
JPS5211589A (en) Apparatus of maintaining cargo in an oil tanker
JPS644608A (en) Heat-treated fluorinated polymeric compound
JPS5281078A (en) Permeable membrane module
JPS51122611A (en) Material for storing hydrogen
JPS5241687A (en) Painted articles onto which unstretched polypripylene films are bonded with heat and pressure
JPS5250040A (en) Emergent cutoff for gas leakage
JPS5231253A (en) Bearing
JPS5234409A (en) Axial blower
JPS5226649A (en) Fluid material and fluid bed drying equipment
JPS527500A (en) Apparatus for drying tobacco leaves
NL7812663A (en) Polymeric filtration membranes - cast from solns. in water-immiscible solvents and immersed in alcohol bath, can be stored in the dry state
CA1004166A (en) Arrangement for hauling up, launching and storing of boats and the like
JPS51117317A (en) Transporting method for liquefied gas by means of cargo tank
JPS5257511A (en) Cylindrical body correcting device

Legal Events

Date Code Title Description
MK1K Patent expired